BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 29258565)

  • 1. A core outcomes set for clinical trials of interventions for young adults with type 1 diabetes: an international, multi-perspective Delphi consensus study.
    Byrne M; O'Connell A; Egan AM; Dinneen SF; Hynes L; O'Hara MC; Holt RIG; Willaing I; Vallis M; Hendrieckx C; Coyne I
    Trials; 2017 Dec; 18(1):602. PubMed ID: 29258565
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 Diabetes (SCORE-IT): study protocol for the development of a core outcome set.
    Harman NL; Wilding J; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
    Trials; 2018 Aug; 19(1):427. PubMed ID: 30086771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Core Outcome Set for Studies on Obesity in Pregnant Patients (COSSOPP): a study protocol.
    Dadouch R; Faheim M; Juando-Prats C; Parsons J; D'Souza R;
    Trials; 2018 Nov; 19(1):655. PubMed ID: 30482249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SCORE-IT (Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes): a systematic review of registered trials.
    Harman NL; James R; Wilding J; Williamson PR;
    Trials; 2017 Dec; 18(1):597. PubMed ID: 29246177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Standardising the reporting of outcomes in gastric cancer surgery trials: protocol for the development of a core outcome set and accompanying outcome measurement instrument set (the GASTROS study).
    Alkhaffaf B; Glenny AM; Blazeby JM; Williamson P; Bruce IA
    Trials; 2017 Aug; 18(1):370. PubMed ID: 28793921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guided self-determination-young versus standard care in the treatment of young females with type 1 diabetes: study protocol for a multicentre randomized controlled trial.
    Haas J; Persson M; Brorsson AL; Toft EH; Olinder AL
    Trials; 2017 Nov; 18(1):562. PubMed ID: 29178923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of a core outcome set for clinical trials in squamous cell carcinoma: study protocol for a systematic review of the literature and identification of a core outcome set using a Delphi survey.
    Schlessinger DI; Iyengar S; Yanes AF; Chiren SG; Godinez-Puig V; Chen BR; Kurta AO; Schmitt J; Deckert S; Furlan KC; Poon E; Cartee TV; Maher IA; Alam M; Sobanko JF
    Trials; 2017 Jul; 18(1):321. PubMed ID: 28701207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Core Outcome Set for Clinical Trials in Non-infectious Uveitis of the Posterior Segment.
    Tallouzi MO; Mathers JM; Moore DJ; Bucknall N; Calvert MJ; Murray PI; Denniston AK;
    Ophthalmology; 2021 Aug; 128(8):1209-1221. PubMed ID: 33515595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Core Outcome Set for GROwth restriction: deVeloping Endpoints (COSGROVE).
    Healy P; Gordijn S; Ganzevoort W; Beune I; Baschat A; Khalil A; Kenny L; Bloomfield F; Daly M; Papageorghiou A; Devane D
    Trials; 2018 Aug; 19(1):451. PubMed ID: 30134949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protocol for the development of a core outcome set for pelvic girdle pain, including methods for measuring the outcomes: the PGP-COS study.
    Wuytack F; Gutke A; Stuge B; Mørkved S; Olsson C; Robinson HS; Vøllestad NK; Öberg B; Wikmar LN; Mena JJS; Smith V
    BMC Med Res Methodol; 2018 Dec; 18(1):158. PubMed ID: 30509216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selecting Core Outcomes for Randomised Effectiveness trials In Type 2 diabetes (SCORE-IT): a patient and healthcare professional consensus on a core outcome set for type 2 diabetes.
    Harman NL; Wilding JPH; Curry D; Harris J; Logue J; Pemberton RJ; Perreault L; Thompson G; Tunis S; Williamson PR;
    BMJ Open Diabetes Res Care; 2019; 7(1):e000700. PubMed ID: 31908789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical Handover Core Outcome Measures (SH-CORE): a protocol for the development of a core outcome set for trials in surgical handover.
    Ryan JM; Devane D; Simiceva A; Eppich W; Kavanagh DO; Cullen C; Hogan AM; McNamara DA
    Trials; 2024 Jun; 25(1):373. PubMed ID: 38858749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Core Outcome Measures in Effectiveness Trials (COMET) initiative: protocol for an international Delphi study to achieve consensus on how to select outcome measurement instruments for outcomes included in a 'core outcome set'.
    Prinsen CA; Vohra S; Rose MR; King-Jones S; Ishaque S; Bhaloo Z; Adams D; Terwee CB
    Trials; 2014 Jun; 15():247. PubMed ID: 24962012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Twin-Twin Transfusion Syndrome: study protocol for developing, disseminating, and implementing a core outcome set.
    Khalil A; Perry H; Duffy J; Reed K; Baschat A; Deprest J; Hecher K; Lewi L; Lopriore E; Oepkes D;
    Trials; 2017 Jul; 18(1):325. PubMed ID: 28709445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The COMiT'ID Study: Developing Core Outcome Domains Sets for Clinical Trials of Sound-, Psychology-, and Pharmacology-Based Interventions for Chronic Subjective Tinnitus in Adults.
    Hall DA; Smith H; Hibbert A; Colley V; Haider HF; Horobin A; Londero A; Mazurek B; Thacker B; Fackrell K;
    Trends Hear; 2018; 22():2331216518814384. PubMed ID: 30488765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COSUTI: a protocol for the development of a core outcome set (COS) for interventions for the treatment of uncomplicated urinary tract infection (UTI) in adults.
    Duane S; Vellinga A; Murphy AW; Cormican M; Smyth A; Healy P; Moore M; Little P; Devane D
    Trials; 2019 Feb; 20(1):106. PubMed ID: 30732617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core outcomes set for research on the treatment of opioid use disorder (COS-OUD): the National Institute on Drug Abuse Clinical Trials Network protocol for an e-Delphi consensus study.
    Karnik NS; Campbell CI; Curtis ME; Fiellin DA; Ghitza U; Hefner K; Hser YI; McHugh RK; Murphy SM; McPherson SM; Moran L; Mooney LJ; Wu LT; Shmueli-Blumberg D; Shulman M; Schwartz RP; Stephens KA; Watkins KE; Marsden J
    Trials; 2021 Jan; 22(1):102. PubMed ID: 33509278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Standardised Outcomes in Nephrology-Children and Adolescents (SONG-Kids): a protocol for establishing a core outcome set for children with chronic kidney disease.
    Tong A; Samuel S; Zappitelli M; Dart A; Furth S; Eddy A; Groothoff J; Webb NJ; Yap HK; Bockenhauer D; Sinha A; Alexander SI; Goldstein SL; Gipson DS; Hanson CS; Evangelidis N; Crowe S; Harris T; Hemmelgarn BR; Manns B; Gill J; Tugwell P; Van Biesen W; Wheeler DC; Winkelmayer WC; Craig JC;
    Trials; 2016 Aug; 17():401. PubMed ID: 27519274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring communication as a core outcome in aphasia trials: Results of the ROMA-2 international core outcome set development meeting.
    Wallace SJ; Worrall L; Rose TA; Alyahya RSW; Babbitt E; Beeke S; de Beer C; Bose A; Bowen A; Brady MC; Breitenstein C; Bruehl S; Bryant L; Cheng BBY; Cherney LR; Conroy P; Copland DA; Croteau C; Cruice M; Dipper L; Hilari K; Howe T; Kelly H; Kiran S; Laska AC; Marshall J; Murray LL; Patterson J; Pearl G; Quinting J; Rochon E; Rose ML; Rubi-Fessen I; Sage K; Simmons-Mackie N; Visch-Brink E; Volkmer A; Webster J; Whitworth A; Dorze GL
    Int J Lang Commun Disord; 2023; 58(4):1017-1028. PubMed ID: 36583427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.